Aug. 29 at 4:49 PM
$SLS $MRK $JNJ Big Pharma is in a massive pipeline crisis, and they desperately need Sellas. Inside the VDR under strict NDAs, the industry is split in two:
🏢 CAMP A: THE SCALERS (Merck/AZ) Pipelines are top-heavy and near-term revenue engines are stalling. They NEED advanced Phase 3 oncology anchors right now to protect market share.
🧬 CAMP B: THE STREAMLINERS (J&J/Roche) Internal discovery engines are completely OFF after slashing early R&D. They MUST buy external, de-risked assets because they outsourced innovation.
Why is management holding through this strict SEC Quiet Period? To completely eliminate the risk-discount before the 80th REGAL event unblinds. Forget complicated CVR milestone nonsense—we want a straight, heavy Upfront Cash + Liquid Stock buyout for immediate monetization.
Let them fight it out to see who writes the biggest upfront check for a total monopoly. SELLAS is not desperate. The BP facing patent cliff is.
